Document is current
Any future updates will be listed below
-
Authors
Chen, Zhongli
Ding, Song
Wang, Yan Ping
Chen, Liang
Mao, Jing Yan
Yang, Ying
Sun, Jia Teng
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04390711 at ClinicalTrials.govDocuments that mention this clinical trial
Association of carbamylated high-density lipoprotein with coronary artery disease in type 2 diabetes mellitus: carbamylated high-density lipoprotein of patients promotes monocyte adhesion
https://doi.org/10.1186/s12967-020-02623-2
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81800223, 81760734, 31660313)
National Natural Science Foundation of China (81770384)
Shanghai Science and Technology Committee (19ZR1430400)
Shanghai Sailing Program (18YF1413500)
the Natural Science Foundation of Yunnan Province (2017FA048)
- License Information
-
More Information
Article History
Received: 10 June 2020
Accepted: 19 November 2020
First Online: 3 December 2020
Ethics approval and consent to participate
: This study protocol was approved by the Institutional Review Board of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. Each subject provided written informed consent and all clinical investigations were conducted in accordance with the ethical standards of the Helsinki Declaration.
: Not applicable.
: The authors declare that they have no competing interests.
